公司资料
OncoMed Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- OMED
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
目前无法获取 OMED 的收盘价变动背景。
公司概览
业务概览
OncoMed was an oncology company focused on cancer stem cells and targeted cancer biology before its restructuring and decline. Its work centered on early immuno-oncology and tumor biology.
所在地与行业分类
Headquartered in the United States and formerly listed on NASDAQ, OncoMed sat in oncology biotechnology.
商业模式特征
The company depended on clinical development, platform validation, and strategic progress.
生物医药行业定位
OncoMed belongs to the historical oncology-biotech category rather than the current live public-company set.
未来催化剂
- OncoMed is now a legacy / closeout story, so the catalysts are any residual asset or corporate-resolution update. There is no broad live pipeline driving the name.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。